Vanguards of Health Care by Bloomberg Intelligence Podcast Por Bloomberg arte de portada

Vanguards of Health Care by Bloomberg Intelligence

Vanguards of Health Care by Bloomberg Intelligence

De: Bloomberg
Escúchala gratis

Vanguards of Health Care is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.

2025 Bloomberg
Economía Finanzas Personales Higiene y Vida Saludable
Episodios
  • Inside .406 Ventures’ Vision for Fixing Health Care’s Hardest Problems
    Jul 17 2025

    “We don’t have to do every great deal, but every deal we do has to be great,” says Payal Agrawal Divakaran, partner at .406 Ventures. In this Vanguards of Health Care episode, she joins Bloomberg Intelligence analyst Jonathan Palmer to unpack how .406 backs early-stage startups at the intersection of health care, tech and AI. They dive into the firm’s thesis-driven investing, why care delivery must be reimagined for complex populations and what Epic’s priorities mean for hospital-facing AI startups. Plus, the origins of the firm’s baseball-inspired name and why being mission-driven is non-negotiable for its founders.

    See omnystudio.com/listener for privacy information.

    Más Menos
    54 m
  • How Machinify’s AI Platform Is Rewriting the Rules of Payer Ops
    Jul 10 2025

    “We truly see ourselves as an operating system for payers,” says David Pierre, CEO of Machinify. Pierre joins Bloomberg Intelligence analyst Jonathan Palmer to unpack how Machinify is using AI to reimagine payment integrity, turning a manual process into a proactive, tech-enabled platform. They discuss Machinify’s formation from four legacy and technology companies, its AI-first claims strategy and how the team is driving real-time adjudication and measurable cost savings. Pierre also shares what he’s learned from Cerner and Signify, and where Machinify is heading next.

    See omnystudio.com/listener for privacy information.

    Más Menos
    50 m
  • Inside Forbion’s M&A-First Playbook for Building Europe’s Biotech Winners
    Jul 3 2025

    "If a company isn't IPO-ready, it better be M&A-ready," says Nanna Lüneborg of Forbion. She and co-founder Sander Slootweg sit down with Bloomberg Intelligence analyst Sam Fazeli to explain Forbion’s blueprint for success in Europe’s maturing biotech ecosystem. From incubating CNS-focused gene therapy startups to executing €100M+ financing rounds, Forbion’s thesis is rooted in scientific rigor and commercially sound exits. They also share how Europe’s capital scarcity offers hidden advantages—and why late-stage buyers still pay up for must-have innovation.

    See omnystudio.com/listener for privacy information.

    Más Menos
    51 m
Todavía no hay opiniones